Literature DB >> 32124266

Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies.

Romain Demailly1,2, Sylvie Escolano3, Françoise Haramburu4, Pascale Tubert-Bitter3, Ismaïl Ahmed3.   

Abstract

BACKGROUND: Pregnant women are largely exposed to medications. However, knowledge is lacking about their effects on pregnancy and the fetus.
OBJECTIVE: This study sought to evaluate the potential of high-dimensional propensity scores and high-dimensional disease risk scores for automated signal detection in pregnant women from medico-administrative databases in the context of drug-induced prematurity.
METHODS: We used healthcare claims and hospitalization discharges of a 1/97th representative sample of the French population. We tested the association between prematurity and drug exposure during the trimester before delivery, for all drugs prescribed to at least five pregnancies. We compared different strategies (1) for building the two scores, including two machine-learning methods and (2) to account for these scores in the final logistic regression models: adjustment, weighting, and matching. We also proposed a new signal detection criterion derived from these scores: the p value relative decrease. Evaluation was performed by assessing the relevance of the signals using a literature review and clinical expertise.
RESULTS: Screening 400 drugs from a cohort of 57,407 pregnancies, we observed that choosing between the two machine-learning methods had little impact on the generated signals. Score adjustment performed better than weighting and matching. Using the p value relative decrease efficiently filtered out spurious signals while maintaining a number of relevant signals similar to score adjustment. Most of the relevant signals belonged to the psychotropic class with benzodiazepines, antidepressants, and antipsychotics.
CONCLUSIONS: Mining complex healthcare databases with statistical methods from the high-dimensional inference field may improve signal detection in pregnant women.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32124266     DOI: 10.1007/s40264-020-00916-5

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  47 in total

1.  Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

Authors:  Romain Demailly; Sylvie Escolano; Catherine Quantin; Pascale Tubert-Bitter; Ismaïl Ahmed
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-07-30       Impact factor: 2.890

2.  Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.

Authors:  Feifan Liu; Abhyuday Jagannatha; Hong Yu
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

3.  Class-imbalanced subsampling lasso algorithm for discovering adverse drug reactions.

Authors:  Ismaïl Ahmed; Antoine Pariente; Pascale Tubert-Bitter
Journal:  Stat Methods Med Res       Date:  2016-04-25       Impact factor: 3.021

Review 4.  Epidemiology of medications use in pregnancy.

Authors:  Martina Ayad; Maged M Costantine
Journal:  Semin Perinatol       Date:  2015-09-08       Impact factor: 3.300

Review 5.  Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy.

Authors:  Krista F Huybrechts; Brian T Bateman; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-05-10       Impact factor: 2.890

Review 6.  Prescription drug use during pregnancy in developed countries: a systematic review.

Authors:  Jamie R Daw; Gillian E Hanley; Devon L Greyson; Steven G Morgan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-07-20       Impact factor: 2.890

Review 7.  Pharmacokinetics of drugs in pregnancy.

Authors:  Maisa Feghali; Raman Venkataramanan; Steve Caritis
Journal:  Semin Perinatol       Date:  2015-11       Impact factor: 3.300

Review 8.  Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.

Authors:  Gali Pariente; Tom Leibson; Alexandra Carls; Thomasin Adams-Webber; Shinya Ito; Gideon Koren
Journal:  PLoS Med       Date:  2016-11-01       Impact factor: 11.069

9.  Medication use in pregnancy: a cross-sectional, multinational web-based study.

Authors:  A Lupattelli; O Spigset; M J Twigg; K Zagorodnikova; A C Mårdby; M E Moretti; M Drozd; A Panchaud; K Hämeen-Anttila; A Rieutord; R Gjergja Juraski; M Odalovic; D Kennedy; G Rudolf; H Juch; A Passier; I Björnsdóttir; H Nordeng
Journal:  BMJ Open       Date:  2014-02-17       Impact factor: 2.692

Review 10.  Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.

Authors:  Areti Angeliki Veroniki; Patricia Rios; Elise Cogo; Sharon E Straus; Yaron Finkelstein; Ryan Kealey; Emily Reynen; Charlene Soobiah; Kednapa Thavorn; Brian Hutton; Brenda R Hemmelgarn; Fatemeh Yazdi; Jennifer D'Souza; Heather MacDonald; Andrea C Tricco
Journal:  BMJ Open       Date:  2017-07-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.